Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Brigitte Lamy

Brigitte Lamy

Montpellier University France

Lia Monica Junie

Lia Monica Junie

University of Medicine and Pharmacy Romania

Anna Moniuszko-Malinowska

Anna Moniuszko-Malinowska

Medical University of Białystok Poland

Neeraj Kumar Tulara

Neeraj Kumar Tulara

Dr L H Hiranandani Hospital India

Peter Donald

Peter Donald

Stellenbosch University South Africa

Arnold Mervyn Levin

Arnold Mervyn Levin

University of the Witwatersrand South Africa

Pedro Brandao dos Santos Pedrosa

Pedro Brandao dos Santos Pedrosa

Leibniz University Germany

Massimo Clementi

Massimo Clementi

University Vita-Salute San Raffaele Italy

Antimicrobial Congress 2018

About Conference


             “The good physicians treat the disease; The great physicians treat the patient who has the disease.”- William Osler

     Conference Series Ltd  invites all the participants from all over the world to attend ‘ANTIMICROBIAL CONGRESS 2018’ which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

An antimicrobial is an operator who is kill microorganisms or repress their development. They are classified to their mode of activity on particular microorganism. Depending on the range of bacterial species helpless to these specialists antibacterial are classified as wide range, intermediate-spectrum, or narrow- range. Non–pharmaceuticals antimicrobial gives a wide range of chemical and common compounds utilized as antimicrobials. The Immunology of have defense peptides gives assorted activities of HDPs. The utilize and misuse of antimicrobial drugs quickens the rise of drug-resistant strains. Post-antibiotic period alludes to a time when a number of irresistible illnesses will be inert to anti-microbial medicines.            

Multidrug resistant (MDR) are those organisms that resistant to different antimicrobials .Resistant microorganisms (compiling organisms, bacteria, parasites and infections) have the capacity to allow impacts on antimicrobial drugs. Unreasonable utilize of antimicrobial drugs rapidify the origin of drug-resistant strains. Poor contamination control practices, unseemly food-handling and insufficient sterile conditions leads to spread of antimicrobial resistance. Determination of antimicrobial medicate resistance is assessed by lab tests that makes it troublesome for the the confined organisms to develop and survive in the nearness of the sedate. Antimicrobial chemotherapy alludes to the utilize of antimicrobial drugs to treat contamination. Microbial immunology alludes to the interrelationship among irresistible specialists and their has, with microbial and viral pathogenesis and the immunological have reaction to diseases.

Who Should Attend?

          Directors, Head of Department, Professors, Industrial Researchers,  Scientist, Microbiologist,  Cancer Pharmacologists, Cancer Therapists, , Cancer Researchers Clinical Pathologists, Surgical Pathologists, pathologist in training and other healthcare,  professionals interested in the latest advances and techniques in the field. Another segment of target audience is Pharmaceutical researchers, Clinical organizations, Educational institutes. Anatomical Pathologists, Forensic Pathologists etc.,

        The International Conference on Antimicrobial and Antibacterial Agents will exhibit the products and services from commercial and non-commercial organizations like Pathology Lab Equipment manufacturers, Cell Diagnostics laboratories, Clinical Trial Sites, Business delegates and Equipment Manufacturers.

Target Audience:

  Academia: 65% 

Industry: 25%

  Others: 10%

 

Why to attend ANTIMICROBIAL CONGRESS 2018:

 

 Best platform to develop new partnership & collaborations.

 Best location to speed up your route into every territory in the World.

 89% our conference attendees are the Key contact in their labs purchasing decisions.

 Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.

 Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees.

 Network development with both Academia and Business.

For more details please visit : https://antimicrobial.vaccineconferences.com

 

Who should sponsor/exhibit:

•        Basic and Translational Laboratory Researchers      

•        Hospitals

•        Educational Institutes

•        Research Centers

•        Charitable Foundations focused on funding research, advocating for and supporting the needs

Benefits of attending:

•        Networking Opportunities, Grow Your Professional Network

•        Build Your Knowledge Base

•        Expand Your Resources

•        Meet Experts & Influencers Face to Face

•        Learning in a New Space

•        Break Out of Your Comfort Zone

•        New Tips & Tactics

•        Greater Focus

•        The Serendipity of the Random Workshop

 

 

Sessions/Tracks

 

 Track 1:  Antibacterial Pathogens: Alternative Approaches:

The first bacterial genome sequencing was done on 1995 which was take a new era in the field of antimicrobial drug discovers, and it is now the great tools to search whole genome for new antibacterial targets. Biofilms are medically important to accounting for over 80% of microbial infections in the body. Drug resistance bacteria lead to poor clinical outcomes increasing health care and mortality.

 

Track 2:  Antibiotic Therapy and Antibacterial Drugs:

Antibacterial therapy contain an accurate diagnosis of infection, understanding the difference between empiric & definitive therapy, cost effective oral agents for the shortest duration, accounting for the host charterstics that influence antimicrobial activity, recognizing the adverse effects of antimicrobial agents on the host body. An antiseptic is used in living tissues and cells to destroy the  infections which may be living on the tissues. Disinfectant is mean to destroy micro-organisms which can be infect nonliving objects.

 

Track 3:  Antimicrobial Agents and Chemotherapy:

Antimicrobial chemotherapy is a clinical approach of antimicrobial agents to treat infectious disease. There are chemotherapy treatments for bacterial infection, fungal infection, protozoan infections, warm infectious and viral infections. Antimicrobial agents that treat microorganism infections area unit given as medication therapy, equally for plant life, microorganism and protozoan infections area unit they're given as antifungal, antiviral and medication therapy.

 

Track 4: Antibacterial Agents in Clinical Treatment:

 

It is an analysis of the antibacterial clinical development pipeline, including mycobacterium tuberculosis. Resistance is a natural phenomenon which will develop by time. As misuse and overuse of antibiotics at accelerate the development of resistance. Antibiotics should be used for antibacterial treatment. The lack of new quality lead chemicals to test against gram-ve bacteria is another major impediment to discovery.

 

 

Track 5: Pharmalogical Consideration of Antimicrobiology:

The pharmacology of antimicrobial agents are the drugs which is used in the treatment of bacterial infections. Β-lactams are a well established group of antibiotics that include penicillin, cephalosporines, carbapenems and monobactams.

 

Track6:  Antimicrobial Agents and Novel Vaccines:

Vaccines can reduce the prevalence of resistance by reducing the need for antimicrobial use and can reduce its impact by reducing the total number of cases. By reducing the number of pathogens that may be responsible for a particular clinical syndrome, vaccines can permit the use of narrower-spectrum antibiotics for empirical therapy. These effects may be amplified by herd immunity, extending protection to unvaccinated persons in the population. Because much selection for resistance is due to selection on bystander members of the normal flora, vaccination can reduce pressure for resistance even in pathogens not included in the vaccine. Some vaccines have had disproportionate effects on drug-resistant lineages within the target species, a benefit that could be more deliberately exploited in vaccine design.

 

Track7:  Global Antibacterial Drugs Market Key:

Based on drug class, the global antibacterial drugs market is classified into B – lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicol’s, and others. In terms of routes of administration, the global antibacterial drugs market has been segmented into enteral, parenteral and others. Likewise, the global antibacterial drugs market has been further segmented into hospital pharmacies, drug stores and retail pharmacies and online sales, in terms of distribution channel. Analyst predicts that the global antibacterial drugs market to gain significantly from the increasing incidence of infectious diseases.

Track8:  Antimicrobial Textiles Market:

The global antimicrobial textiles market based on agent, application, finishing technique, and region. To forecast the market size, in terms of value and volume, of five main regional markets, namely, Asia-Pacific, Europe, North America, South America, and Middle East & Africa. It is also provide detailed information on the key factors influencing the market growth, such as drivers, restraints, opportunities, and industry-specific challenges. We can strategically analyse micro-markets with respect to individual growth trends, prospects, and contribution to the total market.

 

Track9: Neuroinfectious Diseases :

Infection as a cause of neurologic disease is a prominent feature. Nonepidemic viral infections constitute the majority of infections affecting the nervous system today.  Chronic neurologic disease as a sequel to infection is a relatively new and developing area of both pediatric and adult neurology research. Chief among these disorders is the role of post infectious brain inflammation in epileptogenic.

Track10: Molecular Epidemiology of  Neoplastic and Non-neoplastic disease:

Sever infections represent the main cause of neonatal mortality accounting for more than one million neonatal death. Antibiotics are the common medication in neonatal intensive care unit. While there is a growing choice of agents against multi-resistant gram-positive bacteria, new options for multi-resistant gram-negative bacteria in the clinical practice have decreased significantly in the last 20 years making the treatment of infections caused by multidrug-resistant pathogens challenging mostly in neonates

Track11:  Plant Bacteriology:

Plant bacteriology involves the scientific study of bacteria identification, disease etiology, disease cycles, economic impact, epidemiology of plant diseases, plant disease resistance, the way in which plant diseases affect humans and animals. Some bacteria causes a small proportion of plant diseases, this does not mean that these diseases are unimportant. Pathogenic tests can be done for the prevention of disease.  Both natural and cultivated plants carry genetics disease resistance, but there are numerous examples of devastating plant disease.

 

Track12:  Antimicrobiology in Epidemiology:

Antimicrobial resistance is the epidermis of emerged resistance genes  with variable linked within a verity of genetic elements which is  spread through interconnecting bacterial populations of antimicrobial exposed people, animals and places.  Epidemiology include  causation of diseases, transmission of diseases, forensic epidemiology, Occupational epidemiology, screening and the treatment effects such as in clinical trials

 

Track13Antimicrobial Therapy for Gum Disease:

Antimicrobial oral therapy is a form of oral treatment used to eliminate or reduce the development of bacterial infections in the mouth. The therapy is prevent periodontal disease resulting from infections, which can cause painful, bleeding gums and loosening of your teeth. Antimicrobial mouth rinses are much more powerful than over the counter mouthwashes which is  reducing certain bacteria that cause gum disease to an almost undetectable level.

Track14:  Pediatric Viral Diseases:

Pediatric virology is deals with the viral diseases during early childhood stage or in embryo stage.  It is not an isolated discipline but the syndromes associated with viral infection are modified by the unique characteristics of infancy and childhood.  The most common viral fever in childhood stage is the seasonal flu or influenza. But children can catch milder viral. Mostly the childhood viral infections are not serious and include varieties of illnesses as colds with a sore throat, vomiting and diarrhea, and fever with a rash. But there are some viral illnesses that cause more serious disease, such as measles. That causes a disease named chickenpox which most commonly affecting children. Polio is highly infectious diseases that primarily affects children under five years of age. The most common Pediatric cancers are  leukemia , brain tumors and lymphomas .

Track15: Antibiotic Resistance Leads to Increased Mortality:

Overuse of antibiotics cause killing sensitive bacteria but may be the growth and multiply of resistance bacteria. The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficiency of antibiotics, which have transformed medicine and save millions of lives. Infectious caused by antimicrobial resistant bacteria are associated with susceptible bacteria. The emergence and spread of this bacteria is complex and requires incorporating numerous interrelated facts.

 

Track16: Community Acquired Antimicrobial Resistance: Is It Controllable?

 

 

Market Analysis

Important Scope : Total consumption of antibacterial was 31.94 DDD/1000inh/d (third place in Europe in 2011). In community, the use of penicillin’s, cephalosporins, quinolones and sulfonamides exceeded the median for EU member states 1.78 to 2.46-fold; conversely, the use of tetracyclines, nitrofurantoin, phosphomimic was below the European level for these narrow spectrum antibiotics, 0.61-0.65-fold. The indicators place Romania in the latest positions of quality prescription in community (abuse and broader spectrum antibiotics used 8.14-fold more than narrow spectrum antibiotics). From community sales, 0.61 DDD/1000inh/d were parental antibiotics, more than one fourth of antibiotic consumption in healthcare center, 2.18 DDD/1000inh/d. This level could place Romania in the fourth place among the 18 European states communicating hospital; the most used antibiotics in hospital were penicillin’s, 0.86 DDD/1000inh/d, aminoglycosides, 0.44DDD/1000inh/d and cephalosporins, 0.40 DDD/1000inh/d.

In world wide countries researches are going on microbial agents. In many universities many peoples are found to be do work upon pathology and microbiology. By a surveillance report it is known that  the research about microbiology in Africa 17.0%, in Asia 37.6%, in North America 33.1%, in Australia  5.4% is going on respectively.  

 Universities and Hospitals in Romania:

  • University of Bucharest
  • Politechnica University of Bucharest
  • Babes- Bolyai Universities
  • Transilvania University of Brașov
  • Spiru Haret University
  • West University of Timişoara
  • Technical University of Cluj-Napoca
  • Spiru Haret University
  • West University of Timişoara

 

To Collaborate Scientific Professionals around the World

Conference Date September 10-11, 2018

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

Keytopics

  • Anti-inflammatory Cytokines
  • Antibacterial Copper Alloys
  • Antibacterial Drugs Market
  • Antibacterial Therapy
  • Antibiotic Prophylaxis
  • Antibiotics
  • Antibody Therapy
  • Antimicrobial Activity
  • Antimicrobial Chemotherapy
  • Antimicrobial Drug
  • Antimicrobial Potential Of Bacteriocins
  • Antimicrobial Stewardship
  • Antimicrobial Therapy
  • B-lactamase Action
  • Bacteremia
  • Bacteriostatic Antibiotics
  • Biofilms
  • Biomarkers For Detection Of Colonic Neoplasms
  • Bloodstream Infection
  • CAPEX Cycle
  • Cardiovascular Disease
  • Cephalosporines
  • Chemokines
  • Chronic Neurologic Disease
  • Clindamycin
  • Clinical Immunology
  • Clinical Infectious Diseases
  • Clinical Pharmacology In Drug Development
  • Clostridium Difficult Infection
  • Clostridium Difficult Infection
  • Colitis Antibiotics
  • Cytokine Signaling
  • Diagnosis Of Pathogenic Microorganisms
  • Disease Nosology
  • Drug Design
  • Drug Safety Biomarkers
  • Ebola Haemorrhagic Fever
  • Emerging Infections
  • Emerging Microbes And Infections
  • Emerging Microbes And Infections
  • Food And Environmental Virology
  • Harmacogenetics Of Oral Antidiabetic Drugs
  • Hib Conjugate Vaccine
  • Human Papillomavirus
  • Immunobiology And Pathology
  • Metagenomics
  • Molecular Diagnostics
  • Molecular Pathology Of Protest Cancer
  • Multidrug Resistance
  • Nanotoxicology
  • Neurocystercercosi
  • Neuroepidemiology
  • Nonepidemic Viral Infections
  • Nosocomial Infection
  • Occupational Epidemiology
  • Olive Knot Disease
  • Opportunistic Pathogens
  • Oral Therapy
  • Paediatric Virology
  • Pantoea Agglomerans
  • Pertussis Vaccines
  • Phytobacteriology
  • Prevention Of Infection
  • Procalcitonin
  • Pseudomonas Aeruginosa
  • Pseudomonas Syringe
  • R-Plasmid-mediated Resistance
  • Respiratory Virus Vaccine
  • Septicemia
  • Signalling In The Rhizosphere
  • Sustainable Biopolymers Fibers
  • Toxoplasmosis
  • Toxoplasmosis
  • Vaccine Immunology
  • Vaccines
  • Viral Immunology
  • Viremia
  • Virus Adaptation And Treatment.